当前位置: 首页 >> 检索结果
共有 2000 条符合本次的查询结果, 用时 2.7622269 秒

61. Development and application of an artificial intelligence-assisted endoscopy system for diagnosis of Helicobacter pylori infection: a multicenter randomized controlled study.

作者: Pei-Ying Zou.;Jian-Ru Zhu.;Zhe Zhao.;Hao Mei.;Jing-Tao Zhao.;Wen-Jing Sun.;Guo-Hua Wang.;Dong-Feng Chen.;Li-Lin Fan.;Chun-Hui Lan.
来源: BMC Gastroenterol. 2024年24卷1期335页
The early diagnosis and treatment of Heliobacter pylori (H.pylori) gastrointestinal infection provide significant benefits to patients. We constructed a convolutional neural network (CNN) model based on an endoscopic system to diagnose H. pylori infection, and then examined the potential benefit of this model to endoscopists in their diagnosis of H. pylori infection.

62. A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis.

作者: Tracey L Marsh.;Neehar D Parikh.;Lewis R Roberts.;Myron E Schwartz.;Mindie H Nguyen.;Alex Befeler.;Stephanie Page-Lester.;Nabihah Tayob.;Sudhir Srivastava.;Jo Ann Rinaudo.;Amit G Singal.;K Rajender Reddy.;Jorge A Marrero.
来源: Gastroenterology. 2025年168卷2期316-326.e6页
Better surveillance tests for hepatocellular carcinoma (HCC) are needed. The GALAD score (gender, age, α-fetoprotein [AFP] L3, AFP, and des-γ carboxyprothrombin) has been shown to have excellent sensitivity and specificity for HCC in phase 2 studies. We performed a phase 3 biomarker validation study to compare GALAD with AFP in detecting HCC.

63. Incremental high power radiofrequency ablation with multi-electrodes for small hepatocellular carcinoma: a prospective study.

作者: Sungjun Hwang.;Jae Hyun Kim.;Su Jong Yu.;Jeong Min Lee.
来源: BMC Gastroenterol. 2024年24卷1期280页
Radiofrequency ablation (RFA) offers a minimally invasive treatment for small hepatocellular carcinoma (HCC), but it faces challenges such as high local recurrence rates. This prospective study, conducted from January 2020 to July 2022, evaluated a novel approach using a three-channel, dual radiofrequency (RF) generator with separable clustered electrodes to improve RFA's efficacy and safety. The study employed a high-power, gradual, stepwise RFA method on HCCs (≤ 4 cm), utilizing real-time ultrasound-computed tomography (CT)/magnetic resonance imaging (MRI) fusion imaging. Involving 110 participants with 116 HCCs, the study reported no major complications. Local tumor progression (LTP) and intrahepatic remote recurrence (IRR) rates were low, with promising cumulative incidences at 1, 2, and 3 years for LTP (0.9%, 3.6%, 7.0%) and IRR (13.9%, 20.5%, 31.4%). Recurrence-free survival (RFS) rates were similarly encouraging: LTP (99.1%, 96.4%, 93.0%) and IRR (86.1%, 79.5%, 68.6%). This innovative gradual, incremental high-power RFA technique, featuring a dual switching monopolar mode and three electrodes, represents an effective and safer management option for small HCCs. TRIAL REGISTRATION: clinicaltrial.gov identifier: NCT05397860, first registered on 26/05/2022.

64. Decoding IBS: a machine learning approach to psychological distress and gut-brain interaction.

作者: Astri J Lundervold.;Julie E Billing.;Birgitte Berentsen.;Gülen A Lied.;Elisabeth K Steinsvik.;Trygve Hausken.;Arvid Lundervold.
来源: BMC Gastroenterol. 2024年24卷1期267页
Irritable bowel syndrome (IBS) is a diagnosis defined by gastrointestinal (GI) symptoms like abdominal pain and changes associated with defecation. The condition is classified as a disorder of the gut-brain interaction (DGBI), and patients with IBS commonly experience psychological distress. The present study focuses on this distress, defined from reports of fatigue, anxiety, depression, sleep disturbances, and performance on cognitive tests. The aim was to investigate the joint contribution of these features of psychological distress in predicting IBS versus healthy controls (HCs) and to disentangle clinically meaningful subgroups of IBS patients.

65. Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA).

作者: Virginia C Clark.;Charlie Strange.;Pavel Strnad.;Antonio J Sanchez.;Paul Kwo.;Vitor Magno Pereira.;Bart van Hoek.;Igor Barjaktarevic.;Angelo Guido Corsico.;Monica Pons.;Monica Goldklang.;Meagan Gray.;Brooks Kuhn.;Hugo E Vargas.;John M Vierling.;Raj Vuppalanchi.;Mark Brantly.;Naomi Kappe.;Ting Chang.;Thomas Schluep.;Rong Zhou.;James Hamilton.;Javier San Martin.;Rohit Loomba.
来源: Gastroenterology. 2024年167卷5期1008-1018.e5页
Homozygous ZZ alpha-1 antitrypsin (AAT) deficiency produces mutant AAT (Z-AAT) proteins in hepatocytes, leading to progressive liver fibrosis. We evaluated the safety and efficacy of an investigational RNA interference therapeutic, fazirsiran, that degrades Z-AAT messenger RNA, reducing deleterious protein synthesis.

66. Probiotics for managing patients after bowel preparation for colonoscopy: an interventional, double-arm, open, randomized, multi-center, and national study (COLONSTUDY).

作者: Salvatore E Aragona.;Cristiano Spada.;Luca DE Luca.;Elena Aragona.;Giorgio Ciprandi.; .
来源: Minerva Gastroenterol (Torino). 2024年70卷2期187-196页
Bowel preparation (BP) for colonoscopy induces significant changes in gut microbiota, causing dysbiosis that, in turn, elicits intestinal symptoms. Consequently, probiotics may counterbalance the disturbed microbiota after BP. So, probiotics may restore microbiota homeostasis.

67. Design and evaluation of a colon cancer mobile application.

作者: Amir Sadeghi.;Shiva Salar.;Pardis Ketabi Moghadam.;Makan Cheraghpour.;Raziyeh Ghafouri.
来源: BMC Gastroenterol. 2024年24卷1期185页
Colorectal cancer (CRC) is the third leading cause of cancer and the second cause of cancer-related deaths in the world. Despite the infrastructure and the availability of organized screening programs, participation in their screening programs is less than the set goals. Considering the importance of informing the society about the prevention and early detection of colorectal cancer symptoms and the positive impact of mobile health technologies, the present research was conducted with the aim of designing and evaluating a colon cancer mobile application.

68. Cold Versus Hot Snare Endoscopic Resection of Large Nonpedunculated Colorectal Polyps: Randomized Controlled German CHRONICLE Trial.

作者: Ingo Steinbrück.;Alanna Ebigbo.;Armin Kuellmer.;Arthur Schmidt.;Konstantinos Kouladouros.;Markus Brand.;Teresa Koenen.;Viktor Rempel.;Andreas Wannhoff.;Siegbert Faiss.;Oliver Pech.;Oliver Möschler.;Franz Ludwig Dumoulin.;Martha M Kirstein.;Thomas von Hahn.;Hans-Dieter Allescher.;Stefan K Gölder.;Martin Götz.;Stephan Hollerbach.;Björn Lewerenz.;Alexander Meining.;Helmut Messmann.;Thomas Rösch.;Hans-Peter Allgaier.
来源: Gastroenterology. 2024年167卷4期764-777页
Endoscopic mucosal resection (EMR) is standard therapy for nonpedunculated colorectal polyps ≥20 mm. It has been suggested recently that polyp resection without current (cold resection) may be superior to the standard technique using cutting/coagulation current (hot resection) by reducing adverse events (AEs), but evidence from a randomized trial is missing.

69. Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).

作者: Stephen B Hanauer.;Bruce E Sands.;Stefan Schreiber.;Silvio Danese.;Maria Kłopocka.;Jarosław Kierkuś.;Roman Kulynych.;Maciej Gonciarz.;Artur Sołtysiak.;Patryk Smoliński.;Slobodan Srećković.;Ekaterina Valuyskikh.;Adi Lahat.;Marek Horyński.;Antonio Gasbarrini.;Marina Osipenko.;Vladimir Borzan.;Maciej Kowalski.;Daria Saenko.;Ruslan Sardinov.;Sang Joon Lee.;Sunghyun Kim.;Yunju Bae.;Sunhee Lee.;Seulgi Lee.;Joon Ho Lee.;Siyoung Yang.;Jimin Lee.;Juhyun Lee.;Jong Min Kim.;Gahee Park.;William J Sandborn.;Jean-Frederic Colombel.
来源: Gastroenterology. 2024年167卷5期919-933页
CT-P13 subcutaneous (SC), an SC formulation of the intravenous (IV) infliximab biosimilar CT-P13 IV, creates a unique exposure profile. The LIBERTY studies aimed to demonstrate superiority of CT-P13 SC vs placebo as maintenance therapy in patients with Crohn's disease (CD) and ulcerative colitis (UC).

70. Targeted Screening for Barrett's Esophagus and Esophageal Cancer: Post Hoc Analysis From the Randomized BEST3 Trial.

作者: W Keith Tan.;Roberta Maroni.;Judith Offman.;Shahriar A Zamani.; .;Peter D Sasieni.;Rebecca C Fitzgerald.
来源: Gastroenterology. 2024年167卷4期798-800.e4页

71. Prospective, randomized study comparing two different regimens of split-dose polyethylene glycol and their effect on endoscopic outcomes.

作者: Jawad Abou Zeid.;Souheil Hallit.;Bassem Akiki.;Zeina Abou Zeid.;Charbel Yazbeck.
来源: BMC Gastroenterol. 2024年24卷1期132页
Different split regimens of polyethylene glycol are routinely used and no guidelines are available to select an optimal protocol of ingestion. This study aims to compare the efficacy and side effect profile of two different regimens of polyethylene glycol bowel preparation solution: PEG (3 + 1) vs. PEG (2 + 2).

72. Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial.

作者: Chen Chen.;Daya Zhang.;Shimei Huang.;Fan Zeng.;Da Li.;Xiaodong Zhang.;Runxiang Chen.;Shiju Chen.;Jun Wang.;Feihu Bai.
来源: BMC Gastroenterol. 2024年24卷1期131页
To compare the potential efficacy and safety of dual therapy and quadruple therapy with vonoprazan (VPZ) as well as the standard quadruple therapy of proton pump inhibitor (PPI) for the eradication of Helicobacter pylori (Hp) infection in Hainan province.

73. Comparison of Vonoprazan Versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers Rebleeding After Successful Endoscopic Hemostasis: A Multicenter Randomized Noninferiority Trial.

作者: Tanawat Geeratragool.;Uayporn Kaosombatwattana.;Arpapun Boonchote.;Suvikrom Chatthammanat.;Nutchanun Preechakawin.;Jompol Srichot.;Asawin Sudcharoen.;Pavapol Sirisunhirun.;Panotpol Termsinsuk.;Manus Rugivarodom.;Julajak Limsrivilai.;Monthira Maneerattanaporn.;Nonthalee Pausawasdi.;Somchai Leelakusolvong.
来源: Gastroenterology. 2024年167卷4期778-787.e3页
High-dose proton pump inhibitor (PPI) therapy has been recommended to prevent rebleeding of high-risk peptic ulcer (PU) after hemostasis. Vonoprazan has been proven to be noninferior to PPIs in various acid-related diseases. This study aimed to compare the efficacy of vonoprazan vs PPI for preventing high-risk PU rebleeding after hemostasis.

74. Probiotic mixture in patients after Helicobacter pylori eradication: a real-life experience.

作者: Salvatore E Aragona.;Carlo Fabbri.;Giovanni Cammarota.;Giorgio Ciprandi.; .
来源: Minerva Gastroenterol (Torino). 2024年70卷2期197-207页
Eradication for Helicobacter pylori usually induces digestive dysbiosis that, in turn, elicits symptoms. Consequently, probiotic supplementation may counterbalance the disturbed microbiota after this procedure. So, probiotics may restore microbiota homeostasis quickly relieve complaints.

75. Thoracoabdominal Wall Motion-Guided Biofeedback Treatment of Abdominal Distention: A Randomized Placebo-Controlled Trial.

作者: Elizabeth Barba.;Dan M Livovsky.;Anna Accarino.;Fernando Azpiroz.
来源: Gastroenterology. 2024年167卷3期538-546.e1页
Abdominal distention results from abdominophrenic dyssynergia (ie, diaphragmatic contraction and abdominal wall relaxation) in patients with disorders of gut-brain interaction. This study aimed to validate a simple biofeedback procedure, guided by abdominothoracic wall motion, for treating abdominal distention.

76. Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome.

作者: Karen Van den Houte.;Esther Colomier.;Karen Routhiaux.;Zoë Mariën.;Jolien Schol.;Jasmien Van den Bergh.;Julie Vanderstappen.;Nelle Pauwels.;Annick Joos.;Joris Arts.;Philip Caenepeel.;Frederik De Clerck.;Christophe Matthys.;Ann Meulemans.;Mike Jones.;Tim Vanuytsel.;Florencia Carbone.;Jan Tack.
来源: Gastroenterology. 2024年167卷2期333-342页
The efficacy of a low fermentable oligo-, di-, monosaccharides and polyols (FODMAP) diet in irritable bowel syndrome (IBS) is well established. After the elimination period, a reintroduction phase aims to identify triggers. We studied the impact of a blinded reintroduction using FODMAP powders to objectively identify triggers and evaluated the effect on symptoms, quality of life, and psychosocial comorbidities.

77. Endoscopic Gallbladder Stenting to Prevent Recurrent Cholecystitis in Deferred Cholecystectomy: A Randomized Trial.

作者: Wiriyaporn Ridtitid.;Julalak Karuehardsuwan.;Natee Faknak.;Panida Piyachaturawat.;Phuphat Vongwattanakit.;Santi Kulpatcharapong.;Phonthep Angsuwatcharakon.;Parit Mekaroonkamol.;Pradermchai Kongkam.;Rungsun Rerknimitr.
来源: Gastroenterology. 2024年166卷6期1145-1155页
Endoscopic transpapillary gallbladder stenting (ETGS) has been proposed as one of the adjunctive treatments, apart from antibiotics, before surgery in patients with acute cholecystitis whose cholecystectomy could not be performed or was deferred. Currently, there are no comparative data on the outcomes of ETGS in those who receive and do not receive ETGS. We aimed to compare the rates of recurrent cholecystitis at 3 and 6 months in these 2 groups.

78. Autonomous Artificial Intelligence vs Artificial Intelligence-Assisted Human Optical Diagnosis of Colorectal Polyps: A Randomized Controlled Trial.

作者: Roupen Djinbachian.;Claire Haumesser.;Mahsa Taghiakbari.;Heiko Pohl.;Alan Barkun.;Sacha Sidani.;Jeremy Liu Chen Kiow.;Benoit Panzini.;Simon Bouchard.;Erik Deslandres.;Abla Alj.;Daniel von Renteln.
来源: Gastroenterology. 2024年167卷2期392-399.e2页
Artificial intelligence (AI)-based optical diagnosis systems (CADx) have been developed to allow pathology prediction of colorectal polyps during colonoscopies. However, CADx systems have not yet been validated for autonomous performance. Therefore, we conducted a trial comparing autonomous AI to AI-assisted human (AI-H) optical diagnosis.

79. Comparing the effectiveness of transdiagnostic treatment with acceptance and commitment therapy on emotional disorders, rumination, and life satisfaction in patients with irritable bowel syndrome: a randomized clinical trial.

作者: Homa Shahkaram.;Jafar Sarani Yaztappeh.;Amir Sadeghi.;Amir Sam Kianimoghadam.;Samaneh Soltanabadi.;Maryam Bakhtiari.;Abbas Masjedi Arani.
来源: BMC Gastroenterol. 2024年24卷1期66页
The present study was conducted to compare the effectiveness of transdiagnostic treatment (UP) with the acceptance and commitment therapy (ACT) on the emotional disorders, rumination, and life satisfaction in the patients with irritable bowel syndrome (IBS).

80. A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study.

作者: Nicolette J Rodriguez.;C Sloane Furniss.;Matthew B Yurgelun.;Chinedu Ukaegbu.;Pamela E Constantinou.;Ileana Fortes.;Alyson Caruso.;Alison N Schwartz.;Jill E Stopfer.;Meghan Underhill-Blazey.;Barbara Kenner.;Scott H Nelson.;Sydney Okumura.;Alicia Y Zhou.;Tara B Coffin.;Hajime Uno.;Miki Horiguchi.;Allyson J Ocean.;Florencia McAllister.;Andrew M Lowy.;Alison P Klein.;Lisa Madlensky.;Gloria M Petersen.;Judy E Garber.;Scott M Lippman.;Michael G Goggins.;Anirban Maitra.;Sapna Syngal.
来源: Gastroenterology. 2024年166卷5期872-885.e2页
Genetic testing uptake for cancer susceptibility in family members of patients with cancer is suboptimal. Among relatives of patients with pancreatic ductal adenocarcinoma (PDAC), The GENetic Education, Risk Assessment, and TEsting (GENERATE) study evaluated 2 online genetic education/testing delivery models and their impact on patient-reported psychological outcomes.
共有 2000 条符合本次的查询结果, 用时 2.7622269 秒